Clínica Las Condes S.A. - Laporan Laba Rugi (TTM)

Clínica Las Condes S.A.
CL ˙ SNSE
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Clínica Las Condes S.A. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
Revenue 202,808 212,266 220,659 248,857 269,279 276,854 282,389 279,943 271,371 259,992 245,360 225,539 211,636 202,263 198,852 196,410 186,744 172,060 160,911
Change (%) 4.66 3.95 12.78 8.21 2.81 2.00 -0.87 -3.06 -4.19 -5.63 -8.08 -6.16 -4.43 -1.69 -1.23 -4.92 -7.86 -6.48
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 173,412 175,657 170,563 179,603 185,953 203,105 211,068 210,784 209,941 181,336 171,247 162,433 151,643 149,194 141,720 134,047 133,182 149,299 155,123
Change (%) 1.29 -2.90 5.30 3.54 9.22 3.92 -0.13 -0.40 -13.63 -5.56 -5.15 -6.64 -1.61 -5.01 -5.41 -0.65 12.10 3.90
% of Revenue 85.51 82.75 77.30 72.17 69.06 73.36 74.74 75.30 77.36 69.75 69.79 72.02 71.65 73.76 71.27 68.25 71.32 86.77 96.40
Gross Operating Profit 29,396 36,609 50,096 69,254 83,326 73,750 71,321 69,159 61,430 78,656 74,113 63,106 59,993 53,069 57,132 62,363 53,562 22,760 5,788
Change (%) 24.54 36.84 38.24 20.32 -11.49 -3.29 -3.03 -11.18 28.04 -5.78 -14.85 -4.93 -11.54 7.66 9.16 -14.11 -57.51 -74.57
% of Revenue 14.49 17.25 22.70 27.83 30.94 26.64 25.26 24.70 22.64 30.25 30.21 27.98 28.35 26.24 28.73 31.75 28.68 13.23 3.60
SG&A 26,745 27,092 25,908 26,394 27,267 28,855 31,516 33,179 34,797 42,259 41,996 38,174 42,818 33,870 38,037 41,773 38,481 43,838 57,069
Change (%) 1.30 -4.37 1.87 3.31 5.82 9.22 5.27 4.88 21.45 -0.62 -9.10 12.17 -20.90 12.30 9.82 -7.88 13.92 30.18
% of Revenue 13.19 12.76 11.74 10.61 10.13 10.42 11.16 11.85 12.82 16.25 17.12 16.93 20.23 16.75 19.13 21.27 20.61 25.48 35.47
R&D
Change (%)
% of Revenue
OpEx 201,709 204,357 198,094 207,697 215,063 233,884 244,684 246,172 247,026 231,868 222,896 211,592 210,628 196,546 193,804 189,916 183,686 207,477 226,187
Change (%) 1.31 -3.06 4.85 3.55 8.75 4.62 0.61 0.35 -6.14 -3.87 -5.07 -0.46 -6.69 -1.40 -2.01 -3.28 12.95 9.02
% of Revenue 99.46 96.27 89.77 83.46 79.87 84.48 86.65 87.94 91.03 89.18 90.84 93.82 99.52 97.17 97.46 96.69 98.36 120.58 140.57
Operating Income 1,099 7,909 22,566 41,160 54,216 42,970 37,705 33,771 24,345 28,124 22,463 13,946 1,008 5,717 5,049 6,494 3,058 -35,417 -65,276
Change (%) 619.66 185.31 82.40 31.72 -20.74 -12.25 -10.43 -27.91 15.52 -20.13 -37.91 -92.77 467.30 -11.70 28.63 -52.92 -1,258.34 84.31
% of Revenue 0.54 3.73 10.23 16.54 20.13 15.52 13.35 12.06 8.97 10.82 9.16 6.18 0.48 2.83 2.54 3.31 1.64 -20.58 -40.57
Interest Expense -7,933 -7,117 -7,118 -7,227 -7,388 -7,722 -7,989 -8,294 -8,825 -9,283 -9,834 -10,329 -10,471 -10,568 -10,400 -10,816 -12,239 -12,608 -13,590
Change (%) -10.29 0.02 1.52 2.24 4.52 3.46 3.82 6.40 5.19 5.94 5.03 1.38 0.92 -1.59 4.00 13.16 3.02 7.79
% of Revenue -3.91 -3.35 -3.23 -2.90 -2.74 -2.79 -2.83 -2.96 -3.25 -3.57 -4.01 -4.58 -4.95 -5.22 -5.23 -5.51 -6.55 -7.33 -8.45
Net Income -12,095 -5,280 4,933 19,437 28,622 18,417 13,362 8,916 939 4,047 647 -1,240 -8,998 -8,785 -7,529 -8,361 -15,462 -78,463 -102,602
Change (%) -56.35 -193.43 294.01 47.25 -35.66 -27.45 -33.27 -89.47 330.90 -84.02 -291.74 625.85 -2.37 -14.29 11.04 84.94 407.47 30.76
% of Revenue -5.96 -2.49 2.24 7.81 10.63 6.65 4.73 3.19 0.35 1.56 0.26 -0.55 -4.25 -4.34 -3.79 -4.26 -8.28 -45.60 -63.76

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista